Invention Application
- Patent Title: ANTI-CD3 ANTIBODIES AND USES THEREOF
-
Application No.: US16418082Application Date: 2019-05-21
-
Publication No.: US20200048349A1Publication Date: 2020-02-13
- Inventor: Francois GAUDET , Jill GILES-KOMAR , Bradley HEIDRICH , Chichi HUANG , Colleen KANE , Ronan MCDAID , Jennifer NEMETH-SEAY
- Applicant: Janssen Biotech, Inc.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C07K16/30 ; A61P35/00
Abstract:
The present invention relates to antibodies that specifically bind CD3. The present invention relates to antibodies that specifically bind PSMA. The present invention relates to antibodies that specifically bind CD3 and PSMA. The present invention relates to antibodies that specifically bind IL1RAP. The present invention relates to antibodies that specifically bind CD33. The present invention relates to antibodies that specifically bind CD3 and IL1RAP. The present invention relates to antibodies that specifically bind CD3 and CD33. The present invention relates to antibodies that specifically bind TMEFF2. The present invention relates to antibodies that specifically bind CD3 and TMEFF2. The present invention relates to fragments of the antibodies, polynucleotides encoding the antibodies or fragments thereof, and methods of making and using the same.
Public/Granted literature
- US11603405B2 Anti-CD3 antibodies and uses thereof Public/Granted day:2023-03-14
Information query
